78048 Federal Register / Vol. 88, No. 218 / Tuesday, November 14, 2023 / Notices 

some data elements (e.g., date of birth, 

date of diagnosis, county of residence) 

could potentially be combined with 

other information to identify 

individuals. Private information is not 

disclosed unless otherwise compelled 

by law, and all data are treated in a 

secure manner consistent with the 

technical, administrative, and 

operational controls required by the 

Federal Information Security 

Management Act of 2002 (FISMA) and 

the 2010 National Institute of Standards 

and Technology (NIST) Recommended 

Security Controls for Federal 

Information Systems and Organizations. 

Weekly tables of nationally notifiable 

diseases are available through CDC 

WONDER and www.data.cdc.gov. 

Annual summaries of finalized 

nationally notifiable disease data are 

published on CDC WONDER and 

www.data.cdc.gov and disease-specific 

data are published by individual CDC 

programs. 

The burden estimates include the 

number of hours that the public health 

department uses to process and send 

case notification data from their 

jurisdiction to CDC. Specifically, the 

burden estimates include separate 

burden hours incurred for automated 

and non-automated transmissions, 

separate weekly burden hours incurred 

for modernizing surveillance systems as 

part of CDC’s Data Modernization 

Initiative (DMI) implementation, 

separate burden hours incurred for 

annual data reconciliation and 

submission, and separate one-time 

burden hours incurred for the addition 

of new diseases and data elements. The 

burden estimates for the one-time 

burden for reporting jurisdictions are for 

the addition of case notification data for 

Cronobacter and Ehrlichiosis, new 

notifiable conditions; the addition of 

case notification data for Congenital 

cytomegalovirus infection and 

Toxoplasmosis, new conditions under 

standardized surveillance; and the 

addition of new disease-specific data 

elements for Cronobacter, Hansen’s 

Disease (Leprosy) and Leptospirosis. 

Because there were fewer diseasespecific data elements added in this 

Revision, the total burden hours 

decreased from 18,594 to 18,414. CDC 

requests OMB approval for an estimated 

18,414 annual burden hours from the 

257 respondents. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

States ............................. Weekly (Automated) ............................................ 50 52 20/60 867 

States ............................. Weekly (Non-automated) ..................................... 10 52 2 1,040 

States ............................. Weekly (DMI Implementation) ............................. 50 52 4 10,400 

States ............................. Annual .................................................................. 50 1 75 3,750 

States ............................. One-time Addition of Diseases and Data Elements.50 1 3 150 

Territories ....................... Weekly (Automated) ............................................ 5 52 20/60 87 

Territories ....................... Weekly, Quarterly (Non-automated) .................... 5 56 20/60 93 

Territories ....................... Weekly (DMI Implementation) ............................. 5 52 4 1,040 

Territories ....................... Annual .................................................................. 5 1 5 25 

Territories ....................... One-time Addition of Diseases and Data Elements.5 1 3 15 

Freely Associated States Weekly (Automated) ............................................ 3 52 20/60 52 

Freely Associated States Weekly, Quarterly (Non-automated) .................... 3 56 20/60 56 

Freely Associated States Annual .................................................................. 3 1 5 15 

Freely Associated States One-time Addition of Diseases and Data Elements.3 1 3 9 

Cities .............................. Weekly (Automated) ............................................ 2 52 20/60 35 

Cities .............................. Weekly (Non-automated) ..................................... 2 52 2 208 

Cities .............................. Weekly (DMI Implementation) ............................. 2 52 4 416 

Cities .............................. Annual .................................................................. 2 1 75 150 

Cities .............................. One-time Addition of Diseases and Data Elements.2 1 3 6 

Total ........................ .............................................................................. ........................ ........................ ........................ 18,414 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2023–25088 Filed 11–13–23; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10552] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 88, No. 218 / Tuesday, November 14, 2023 / Notices 78049 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

January 16, 2024. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to https://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: 

CMS, Office of Strategic Operations and 

Regulatory Affairs, Division of 

Regulations Development, Attention: 

Document Identifier/OMB Control 

Number:__, Room C4–26–05, 7500 

Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, please access the CMS PRA 

website by copying and pasting the 

following web address into your web 

browser: https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10552 Implementation of 

Medicare Programs;—Medicare 

Promoting Interoperability Program 

Under the PRA (44 U.S.C. 3501– 

3520), Federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires Federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Implementation 

of Medicare Programs;—Medicare 

Promoting Interoperability Program; 

Use: The Centers for Medicare & 

Medicaid Services (CMS) is requesting 

approval to collect information from 

eligible hospitals and critical access 

hospitals (CAHs). We have finalized 

changes to this program as discussed in 

the FY 2024 Inpatient Prospective 

Payment System (IPPS)/Long-term Care 

Hospital Prospective Payment System 

(LTCH PPS) final rule. This is a revision 

of the information collection request. 

The American Recovery and 

Reinvestment Act of 2009 (Recovery 

Act) (Pub. L. 111–5) was enacted on 

February 17, 2009. Title IV of Division 

B of the Recovery Act amended Titles 

XVIII and XIX of the Social Security Act 

(the Act) by establishing incentive 

payments to eligible professionals (EPs), 

eligible hospitals and CAHs, and 

Medicare Advantage (MA) organizations 

participating in the Medicare and 

Medicaid programs that adopt and 

successfully demonstrate meaningful 

use of certified EHR technology 

(CEHRT). These Recovery Act 

provisions, together with Title XIII of 

Division A of the Recovery Act, may be 

cited as the ‘‘Health Information 

Technology for Economic and Clinical 

Health Act’’ or the ‘‘HITECH Act.’’ 

The HITECH Act created incentive 

programs for EPs, eligible hospitals 

including CAHs, and MA organizations 

in the Medicare Fee-for-Service (FFS), 

and Medicaid programs that 

successfully demonstrated meaningful 

use of CEHRT. In their first payment 

year, Medicaid EPs, eligible hospitals 

including MA organizations and CAHs 

could adopt, implement, or upgrade to 

certified EHR technology. It also 

allowed for negative payment 

adjustments in the Medicare FFS and 

MA programs starting in 2015 for EPs, 

eligible hospitals including MA 

organizations and CAHs participating in 

Medicare that are not meaningful users 

of CEHRT. The Medicaid Promoting 

Interoperability Program did not 

authorize negative payment 

adjustments, but its participants were 

eligible for incentive payments until 

December 31, 2021, when the program 

ended. 

In CY 2017, we began collecting data 

from eligible hospitals and CAHs to 

determine the application of the 

Medicare payment adjustments. This 

information collection was also used to 

make incentive payments to eligible 

hospitals in Puerto Rico from 2016 

through 2021. At this time, Medicare 

eligible professionals no longer reported 

to the EHR Incentive Program, as they 

began reporting under the Merit-based 

Incentive Payment System’s (MIPS) 

Promoting Interoperability Performance 

Category. In 2019, the EHR Incentives 

Program for eligible hospitals and CAHs 

was subsequently renamed the Medicare 

Promoting Interoperability Program. In 

subsequent years, we have focused on 

balancing reporting burden for eligible 

hospitals and CAHs while also 

implementing changes designed to 

incentivize the advanced use of CEHRT 

to support health information exchange, 

interoperability, advanced quality 

measurement, and maximizing clinical 

effectiveness and efficiencies. 

In the FY 2024 IPPS/LTCH PPS final 

rule, we finalized the following policy 

changes for eligible hospitals and CAHs 

that attest to CMS under the Medicare 

Promoting Interoperability Program. 

None of the policies we finalized will 

affect the information collection burden: 

(i) to adopt three electronic clinical 

quality measures (eCQMs) beginning 

with the CY 2025 reporting period: (1) 

Hospital Harm—Pressure Injury eCQM; 

(2) Hospital Harm—Acute Kidney Injury 

eCQM; and (3) Excessive Radiation Dose 

or Inadequate Image Quality for 

Diagnostic Computed Tomography 

(CMT) in Adults eCQM; (ii) to modify 

the Safety Assurance Factors for EHR 

Resilience (SAFER) Guides measure to 

require eligible hospitals and CAHs to 

submit a ‘‘yes’’ attestation to fulfill the 

measure beginning with the EHR 

reporting period in CY 2024; and (iii) to 

establish an EHR reporting period of a 

minimum of any continuous 180-day 

period in CY 2025. Form Number: 

CMS–10552 (OMB control number: 

0938–1278); Frequency: Annually; 

Affected Public: State, Local or Private 

Government; Business and for-profit 

and Not-for-profit; Number of 


khammond on DSKJM1Z7X2PROD with NOTICES
78050 Federal Register / Vol. 88, No. 218 / Tuesday, November 14, 2023 / Notices 

Respondents: 4,500; Total Annual 

Responses: 4,500; Total Annual Hours: 

29,625. (For policy questions regarding 

this collection, contact Jessica Warren at 

410–786–7519.) 

Dated: November 8, 2023. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2023–25059 Filed 11–13–23; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Rural Health Information 

Clearinghouse Program 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Announcing Funding 

Supplement for National Rural Health 

Information Clearinghouse Program 

recipient. 

SUMMARY: HRSA provided supplemental 

award funds to the National Rural 

Health Information Clearinghouse 

Program recipient to develop toolkits 

and other resources that address 

strategies to promote rural community 

health. 

FOR FURTHER INFORMATION CONTACT: 

Sarah Scott, Federal Office of Rural 

Health Policy, HRSA, at sscott2@

hrsa.gov and (301) 287–2619. 

SUPPLEMENTARY INFORMATION: 

Intended Recipient of the Award: The 

University of North Dakota. 

Amount of Non-Competitive Award: 

One award for $485,000. 

Project Period: June 1, 2023, to May 

31, 2024. 

CFDA Number: 93.223. 

Award Instrument: Supplement. 

Authority: Social Security Act 711(b) 

(42 U.S.C. 912(b)). 

TABLE 1—RECIPIENTS AND AWARD AMOUNTS

Grant No. Award recipient name City, State Supplemental 

award amount 

U56RH05539 ........................................... University of North Dakota ...................... Grand Forks, ND ..................................... $485,000 

Justification: This funding will 

provide a one-time supplement to the 

University of North Dakota via the 

National Rural Health Information 

Clearinghouse Program. This 

supplement will allow the University of 

North Dakota to build on past and 

ongoing projects supported by HRSA to 

improve health care in rural areas by 

serving as a primary resource for 

information, opportunities, and tools 

related to rural health. The supplement 

will allow the University of North 

Dakota to create new toolkits and 

resources on important topics related to 

rural community health. This builds 

upon the planned work within the 

scope of its existing award. 

Carole Johnson, 

Administrator. 

[FR Doc. 2023–25068 Filed 11–13–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

National Vaccine Injury Compensation 

Program; List of Petitions Received 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HRSA is publishing this 

notice of petitions received under the 

National Vaccine Injury Compensation 

Program (the Program), as required by 

the Public Health Service (PHS) Act, as 

amended. While the Secretary of HHS is 

named as the respondent in all 

proceedings brought by the filing of 

petitions for compensation under the 

Program, the United States Court of 

Federal Claims is charged by statute 

with responsibility for considering and 

acting upon the petitions. 

FOR FURTHER INFORMATION CONTACT: For 

information about requirements for 

filing petitions, and the Program in 

general, contact Lisa L. Reyes, Clerk of 

Court, United States Court of Federal 

Claims, 717 Madison Place NW, 

Washington, DC 20005, (202) 357–6400. 

For information on HRSA’s role in the 

Program, contact the Director, National 

Vaccine Injury Compensation Program, 

5600 Fishers Lane, Room 08N146B, 

Rockville, Maryland 20857; (301) 443– 

6593, or visit our website at: http://

www.hrsa.gov/vaccinecompensation/ 

index.html. 

SUPPLEMENTARY INFORMATION: The 

Program provides a system of no-fault 

compensation for certain individuals 

who have been injured by specified 

childhood vaccines. Subtitle 2 of title 

XXI of the PHS Act, 42 U.S.C. 300aa– 

10 et seq., provides that those seeking 

compensation are to file a petition with 

the United States Court of Federal 

Claims and to serve a copy of the 

petition to the Secretary of HHS, who is 

named as the respondent in each 

proceeding. The Secretary has delegated 

this responsibility under the Program to 

HRSA. The Court is directed by statute 

to appoint special masters who take 

evidence, conduct hearings as 

appropriate, and make initial decisions 

as to eligibility for, and amount of, 

compensation. 

A petition may be filed with respect 

to injuries, disabilities, illnesses, 

conditions, and deaths resulting from 

vaccines described in the Vaccine Injury 

Table (the Table) set forth at 42 CFR 

100.3. This Table lists for each covered 

childhood vaccine the conditions that 

may lead to compensation and, for each 

condition, the time period for 

occurrence of the first symptom or 

manifestation of onset or of significant 

aggravation after vaccine 

administration. Compensation may also 

be awarded for conditions not listed in 

the Table and for conditions that are 

manifested outside the time periods 

specified in the Table, but only if the 

petitioner shows that the condition was 

caused by one of the listed vaccines. 

Section 2112(b)(2) of the PHS Act, 42 

U.S.C. 300aa–12(b)(2), requires that 

‘‘[w]ithin 30 days after the Secretary 

receives service of any petition filed 

under section 2111 the Secretary shall 

publish notice of such petition in the 

Federal Register.’’ Set forth below is a 

list of petitions received by HRSA on 

September 1, 2023, through September 

30, 2023. This list provides the name of 

the petitioner, city, and state of 

vaccination (if unknown then the city 

and state of the person or attorney filing 

the claim), and case number. In cases 

where the Court has redacted the name 


khammond on DSKJM1Z7X2PROD with NOTICES